NCT00203632View on ClinicalTrials.gov

Glitazones and Endothelial Function (GATE)

PHASE3TerminatedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

October 31, 2007

Conditions

Diabetes Mellitus

Interventions

DRUG

rosiglitazone/placebo

Trial Locations (1)

T2N 2T9

Foothills Medical Centre, Calgary

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Calgary

OTHER